Safety and Efficacy of Albiglutide in Type 2 Diabetes

Summary

The purpose of this study is to determine the safety, tolerability and efficacy of albiglutide in the treatment of type 2 diabetes.

Timeline

Start

2009-01

Primary completion

2011-11

Completion

2013-01

Outcome

Met primary endpoint

registry p <0.0001; Mean Difference (Net) -0.75 (95% CI -0.95 to -0.56); ANCOVA NCT00849056 ↗

Publications

• Home PD, Ahren B, Reusch JEB, Rendell M, Weissman PN, Cirkel DT, Miller D, Ambery P, Carr MC, Nauck MA. Three-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus: Long-term efficacy with or without rescue therapy. Diabetes Res Clin Pract. 2017 Sep;131:49-60. doi: 10.1016/j.diabres.2017.06.013. Epub 2017 Jun 15.

Drugs

Indications